Cash Flow

CONDENSED CONSOLIDATED STATEMENT OF CASH FLOWS (Unaudited) - USD ($)	9 Months Ended
	Sep. 30, 2019	Sep. 30, 2018
Cash flows from operating activities:
Net loss	$ (4,437,326)	$ (1,462,467)
Adjustments to reconcile net loss to net cash used in operations
Non-cash interest expense	1,263,745	1,222,556
Amortization and depreciation	61,258	7,626
Loss (Gain) on fair value change of derivatives	453,770	(235,194)
Loss (Gain) on extinguishment of debt	797,996	(425,595)
Stock compensation expense	824,416	42,083
Issuance of convertible notes for fees		9,500
Impairment of intangible asset	44,200
Changes in operating assets and liabilities:
Inventory	1,625	19,734
Accounts receivable	8,593	(32,092)
Prepaid assets	7,839	21,797
Accounts payable and accrued expenses	226,688	133,400
Accounts payable and accrued expenses, related parties	(839)	224,736
Net cash used in operating activities	(748,035)	(473,916)
Cash flows from investing activities:
Payment of license fees	(200,000)
Cash acquired in acquisitions		21,580
Purchase of office and computer equipment		(4,941)
Payments for extensions of patents		(13,400)
Net cash provided by (used in) investing activities	(200,000)	3,239
Cash flows from financing activities:
Redemption of common stock		(350,000)
Proceeds from sale of common stock	100,000	250,000
Proceeds from issuances of convertible notes payable	890,450	730,000
Proceeds from issuances of notes payable	15,000	200,000
Payments of principal of convertible note payable and notes payable	(107,113)	(386,846)
Net cash provided by financing activities	898,337	443,154
Effects of exchange rate on cash and cash equivalents	11	(4,157)
Net decrease in cash	(49,687)	(31,680)
Cash, Beginning of period	50,903	110,792
Cash, End of period	1,216	79,112
Supplemental disclosure of cash flow information:
Cash paid for interest	65,656	36,596
Cash paid for income taxes
Schedule of non-cash Investing or Financing Activity:
Original issue discount included in notes payable	119,875	186,425
Issuance of common stock upon convertible note and accrued interest conversion	324,584	589,176
Acquisition of Spinal Resources, Inc.
Acquisitions
Cash paid	200,000
Issuance of Common stock as consideration	49,000
Assumed liabilities	524,387
Issuance of note as consideration	768,844
Common stock to be issued	245,000
License fee payable	1,234,089
Present value of option to buy SRI	2,834,692
Inventory	(389,634)
Fixed Assets	(379,210)
Patent rights	(2,810,000)
Goodwill	(2,277,168)
Cash acquired
Acquisition of Spinus, LLC
Acquisitions
Issuance of Common stock as consideration		250,000
Assumed liabilities		278,779
Accounts receivable		(19,054)
Other Assets		(250,000)
Tradename		(44,200)
Goodwill		(194,951)
Cash acquired		20,574
Acquisition of Newmarkt
Acquisitions
Issuance of Common stock as consideration		2,798
Assumed liabilities		62,464
Paid in capital		(53,990)
Inventory		(8,359)
Prepaid expenses		(1,907)
Cash acquired		$ 1,006